3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
71
Breast Neoplasms
45
Neoplasms
29
Carcinoma, Non-Small-Cell Lung
29
Triple Negative Breast Neoplasms
21
Neoplasm Metastasis
14
Adenocarcinoma
13
Squamous Cell Carcinoma of Head and Neck
8
Lung Neoplasms
8
Colorectal Neoplasms
8
Melanoma
7
Carcinoma
7
Head and Neck Neoplasms
6
Digestive System Neoplasms
6
Cholangiocarcinoma
6
Small Cell Lung Carcinoma
5
Pancreatic Diseases
5
Pancreatic Adenocarcinoma
5
Ovarian Neoplasms
5
Digestive System Diseases
5
Carcinoma, Pancreatic Ductal
5
Stomach Neoplasms
4
Sarcoma
4
Recurrence
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Neoplasms by Site
4
Gallbladder Neoplasms
4
Fallopian Tube Neoplasms
4
Endocrine Gland Neoplasms
4
Carcinoma, Squamous Cell
4
Interventions
Blood Specimen Collection
13
Reverse Transcriptase Polymerase Chain Reaction
7
Flow Cytometry
7
Surgical Procedures, Operative
3
Pirinitramide
2
Morphine
2
Bevacizumab
2
ribociclib
1
lanreotide
1
jinfukang
1
eribulin
1
cabazitaxel
1
Zoledronic Acid
1
Vinorelbine
1
Trastuzumab
1
Thiotepa
1
Taxes
1
Stem Cell Transplantation
1
Standard of Care
1
Spinal Puncture
1
Sorafenib
1
Radiofrequency Ablation
1
Propofol
1
Pemetrexed
1
Octreotide
1
Letrozole
1
Lapatinib
1
Injections, Epidural
1
Injections
1
Hematologic Tests
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neoplastic Cells, Circulating
×
130-nm albumin-bound paclitaxel
×
Clear all
NCT02707159
2023-03-08
PACT-ACT-v6
Helse Stavanger HF
Phase 2
Completed
70 enrolled